Emeis EMEIS
EURONEXT · France · Health Services
€10.10-0.22 (-2.13%)
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · EUR · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Emeis (WBO:ORP2) reports 6% like-for-like revenue growth and raises full-year EBITDA guidance to 12-14% growth, despite persistent net losses and cash flow headwinds.
PUTEAUX, France, July 30, 2026--Regulatory News: emeis (Paris:EMEIS):
PUTEAUX, France, July 29, 2026--Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260729930934/en/
PUTEAUX, France, July 03, 2026--Regulatory News: Under the liquidity agreement entrusted by emeis (the "Company") (Paris:EMEIS) to Natixis Oddo BHF, the following resources were recorded in the dedicated liquidity account as of 30 June 2026:
PUTEAUX, France, June 30, 2026--Regulatory News: After four years of profound transformation, emeis is entering a new chapter. Thanks to the remarkable commitment of the teams, emeis (Paris:EMEIS) has found itself on a sustainable path with good momentum. Today, building on these solid foundations, Laurent Guillot, Chief Executive Officer, is making changes to emeis’ organisational structure in order to support further growth and continue to improve the quality of care provided to patients, resi
PUTEAUX, France, June 23, 2026--Regulatory News: emeis (Paris:EMEIS):
Emeis (WBO:ORP2) reports robust financial performance with significant revenue growth, improved cash flow, and strategic refinancing, despite challenges in specific regions.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.